Briacell Therapeutics -CW27BCTXWPreferred / convertible
13F holders, Q1 2024 (March 31)3holders
$1.35avg. 13F price*
At the end of Q1 2024, 3 institutions reported holding Briacell Therapeutics -CW27 (BCTXW) in their 13F filings. The largest holders were Armistice Capital, LLC ($510K), Redmond Asset Management, LLC ($98K) and Osaic Holdings, Inc. ($1K).
- Company
- Briacell Therapeutics -CW27
- CUSIP
- 10778Y112
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $1K |
| Exits | 0 | $0 |
Ownership 3 holders
| Armistice Capital, LLC | — | No change | 375,000 | $510K |
| Redmond Asset Management, LLC | — | No change | 75,000 | $98K |
| Osaic Holdings, Inc. | — | New | 800 | $1K |
"% of holder's portfolio" is BCTXW's weight in each manager's 13F, not the share of Briacell Therapeutics -CW27 the manager owns.